PAMP
BPMC

Polar Asset Management Partners’s Blueprint Medicines BPMC Stock Holding History

Polar Asset Management Partners’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-262,964
Closed -$33.7M – 691
2025
Q2 		$33.7M Buy
+262,964
New +$27.3M 0.53% 20

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Polar Asset Management Partners's BPMC Position: Q3 2025 in Review

Polar Asset Management Partners sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 262,964 shares — an estimated $33.7M sold.

Polar Asset Management Partners first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $33.7M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Polar Asset Management Partners reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 262,964 Blueprint Medicines shares in Q3 2025, an estimated $33.7M.
  • Polar Asset Management Partners first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • Polar Asset Management Partners's Blueprint Medicines position peaked at $33.7M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Polar Asset Management Partners's 13F filing for Q3 2025, filed 14 Nov 2025.